| Primary |
| Angina Pectoris |
20.0% |
| Depression |
20.0% |
| Gastric Ulcer |
20.0% |
| Gastritis |
20.0% |
| Prostate Cancer |
20.0% |
|
| Respiratory Failure |
100.0% |
|
| Secondary |
| Prostate Cancer |
34.9% |
| Drug Use For Unknown Indication |
30.2% |
| Prostate Cancer Stage Iv |
15.9% |
| Prostate Cancer Stage Iii |
12.7% |
| Depression |
1.6% |
| Gastritis |
1.6% |
| Hypertension |
1.6% |
| Pneumonia Staphylococcal |
1.6% |
|
| Vomiting |
28.6% |
| Urinary Retention |
14.3% |
| Urinary Tract Infection |
14.3% |
| Interstitial Lung Disease |
7.1% |
| Liver Disorder |
7.1% |
| Lymphoma |
7.1% |
| Myelodysplastic Syndrome |
7.1% |
| Pulmonary Oedema |
7.1% |
| Thrombocytopenia |
7.1% |
|
| Concomitant |
| Prostate Cancer Stage Iv |
58.3% |
| Hypertension |
4.5% |
| Cancer Pain |
4.2% |
| Prostate Cancer |
3.7% |
| Benign Prostatic Hyperplasia |
3.6% |
| Constipation |
3.3% |
| Diabetes Mellitus |
2.3% |
| Gastritis |
2.3% |
| Gastric Ulcer |
2.0% |
| Prostate Cancer Stage Iii |
2.0% |
| Product Used For Unknown Indication |
1.8% |
| Drug Use For Unknown Indication |
1.7% |
| Prostate Cancer Stage Ii |
1.7% |
| Gastrointestinal Disorder |
1.5% |
| Metastases To Bone |
1.5% |
| Gastritis Prophylaxis |
1.3% |
| Prophylaxis |
1.2% |
| Metastatic Pain |
1.1% |
| Thrombosis Prophylaxis |
1.0% |
| Back Pain |
0.8% |
|
| Prostate Cancer |
42.5% |
| Prostate Cancer Stage Iv |
21.2% |
| Prostatic Specific Antigen Increased |
8.0% |
| Metastases To Bone |
4.7% |
| Gallbladder Perforation |
2.8% |
| Respiratory Arrest |
1.9% |
| Weight Decreased |
1.9% |
| Cardiac Failure |
1.4% |
| Cerebral Infarction |
1.4% |
| Disseminated Intravascular Coagulation |
1.4% |
| Hepatic Rupture |
1.4% |
| Injection Site Induration |
1.4% |
| Lung Neoplasm Malignant |
1.4% |
| Perineal Pain |
1.4% |
| Renal Failure Acute |
1.4% |
| Skin Ulcer |
1.4% |
| Trigger Finger |
1.4% |
| Colon Cancer |
0.9% |
| Diplegia |
0.9% |
| Febrile Neutropenia |
0.9% |
|
